AmyriAD Therapeutics
Recent News About AmyriAD Therapeutics
-
8 Los Angeles biopharma companies could be negatively impacted by Inflation Reduction Act drug provision
A provision of the “Inflation Reduction Act” (IRA) could threaten investments in "small molecule" drug development, said the head of the Pasadena-based Pacific Research Institute (PRI).